Hypertension pulmonaire : physiopathologie et innovation thérapeutique

483 papers and 13.2k indexed citations i.

About

In recent decades, authors affiliated with Hypertension pulmonaire : physiopathologie et innovation thérapeutique have published 483 papers, which have received a total of 13.2k indexed citations. Scholars at this organization have produced 259 papers in Pulmonary and Respiratory Medicine, 115 papers in Cardiology and Cardiovascular Medicine and 106 papers in Surgery on the topics of Pulmonary Hypertension Research and Treatments (161 papers), Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis (38 papers) and Cardiovascular Function and Risk Factors (35 papers). Their work is cited by papers focused on Pulmonary and Respiratory Medicine (6.4k citations), Cardiology and Cardiovascular Medicine (3.1k citations) and Surgery (2.9k citations). Authors at Hypertension pulmonaire : physiopathologie et innovation thérapeutique collaborate with scholars in France, United States and United Kingdom and have published in prestigious journals including Proceedings of the National Academy of Sciences, The Lancet and Circulation. Some of Hypertension pulmonaire : physiopathologie et innovation thérapeutique's most productive authors include Marc Humbert, David Montani, Frédéric Perros, Peter Dorfmüller, Christophe Guignabert, Gérald Simonneau, Jean‐Louis Teboul, Xavier Jaïs, Sylvia Cohen‐Kaminsky and Olivier Sitbon.

In The Last Decade

Fields of papers published by authors at Hypertension pulmonaire : physiopathologie et innovation thérapeutique

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers affiliated with Hypertension pulmonaire : physiopathologie et innovation thérapeutique at the time of their publication. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers affiliated with Hypertension pulmonaire : physiopathologie et innovation thérapeutique at the time of their publication.

Countries citing scholars working at Hypertension pulmonaire : physiopathologie et innovation thérapeutique

Since Specialization
Citations

This map shows the geographic impact of research produced by authors working at Hypertension pulmonaire : physiopathologie et innovation thérapeutique. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by papers produced at Hypertension pulmonaire : physiopathologie et innovation thérapeutique with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hypertension pulmonaire : physiopathologie et innovation thérapeutique more than expected).

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar’s output or impact.

Explore institutions with similar magnitude of impact

Rankless by CCL
2025